Clinical Trial: A Study to Assess the Efficacy and Safety of Elismetrep (K-304) in the Acute Treatment of Migraine

U.S., Sept. 12 -- ClinicalTrials.gov registry received information related to the study (NCT07816367) titled 'A Study to Assess the Efficacy and Safety of Elismetrep (K-304) in the Acute Treatment of Migraine' on Sept. 07.

Brief Summary: This is a double-blind, randomized, multicenter, outpatient evaluation of the safety and efficacy of elismetrep, as compared with placebo, in the treatment of moderate or severe of migraine.

Study Start Date: Sept., 2026

Study Type: INTERVENTIONAL

Condition: Migraine

Intervention: DRUG: Elismetrep

Administered orally

DRUG: Placebo

Administered orally

Recruitment Status: NOT_YET_RECRUITING

Sponsor: Kallyope Inc.

Disclaimer: Curated by HT Syndication....